Go offline with the Player FM app!
The Markets, Final Presidential Debate, FDA Approves First Treatment For COVID-19 And Intel Tumbles
Manage episode 393101419 series 2534991
Carl Quintanilla, Jim Cramer and David Faber explored a number of issues on Wall Street's radar: The second and final presidential debate of the 2020 election - including reaction to President Trump's vaccine timeline, Gilead shares rising after its
antiviral remdesivir became the first drug to receive FDA approval for treatment of COVID-19, and Intel shares tumbling after weakness in the chip maker's data center business impacted quarterly results.
Also in focus: Apple's new iPhone 12 hitting stores in China and what to expect from sales of the device in the U.S., plus the stock winners and losers to cap what has been a busy week on the earnings front.
1497 episodes
Manage episode 393101419 series 2534991
Carl Quintanilla, Jim Cramer and David Faber explored a number of issues on Wall Street's radar: The second and final presidential debate of the 2020 election - including reaction to President Trump's vaccine timeline, Gilead shares rising after its
antiviral remdesivir became the first drug to receive FDA approval for treatment of COVID-19, and Intel shares tumbling after weakness in the chip maker's data center business impacted quarterly results.
Also in focus: Apple's new iPhone 12 hitting stores in China and what to expect from sales of the device in the U.S., plus the stock winners and losers to cap what has been a busy week on the earnings front.
1497 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.